Correlation Between ICL Israel and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ICL Israel and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ICL Israel and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ICL Israel Chemicals and Sartorius Stedim Biotech, you can compare the effects of market volatilities on ICL Israel and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ICL Israel with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of ICL Israel and Sartorius Stedim.

Diversification Opportunities for ICL Israel and Sartorius Stedim

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between ICL and Sartorius is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding ICL Israel Chemicals and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and ICL Israel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ICL Israel Chemicals are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of ICL Israel i.e., ICL Israel and Sartorius Stedim go up and down completely randomly.

Pair Corralation between ICL Israel and Sartorius Stedim

Considering the 90-day investment horizon ICL Israel is expected to generate 1.55 times less return on investment than Sartorius Stedim. But when comparing it to its historical volatility, ICL Israel Chemicals is 1.07 times less risky than Sartorius Stedim. It trades about 0.08 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  21,800  in Sartorius Stedim Biotech on April 19, 2025 and sell it today you would earn a total of  2,635  from holding Sartorius Stedim Biotech or generate 12.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

ICL Israel Chemicals  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
ICL Israel Chemicals 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ICL Israel Chemicals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent fundamental indicators, ICL Israel may actually be approaching a critical reversion point that can send shares even higher in August 2025.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical indicators, Sartorius Stedim reported solid returns over the last few months and may actually be approaching a breakup point.

ICL Israel and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ICL Israel and Sartorius Stedim

The main advantage of trading using opposite ICL Israel and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ICL Israel position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind ICL Israel Chemicals and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios